Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
United Therapeutics Corporation - Common Stock
(NQ:
UTHR
)
522.83
-9.70 (-1.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about United Therapeutics Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
2 Value Stocks on Our Watchlist and 1 to Ignore
March 12, 2025
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...
Via
StockStory
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025
March 04, 2025
From
United Therapeutics Corporation
Via
Business Wire
Why United Therapeutics (UTHR) Stock Is Down Today
February 26, 2025
Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 10.9% in the afternoon session after the company reported disappointing fourth-quarter results: EPS missed analysts' expectations,...
Via
StockStory
United Therapeutics (NASDAQ:UTHR) Reports Q4 In Line With Expectations
February 26, 2025
Biotechnology company United Therapeutics (NASDAQ:UTHR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per share was...
Via
StockStory
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
How Is The Market Feeling About United Therapeutics?
↗
January 01, 2025
Via
Benzinga
$1000 Invested In United Therapeutics 20 Years Ago Would Be Worth This Much Today
↗
December 11, 2024
Via
Benzinga
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
February 26, 2025
From
United Therapeutics Corporation
Via
Business Wire
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings
February 25, 2025
Biotechnology company United Therapeutics (NASDAQ:UTHR) will be reporting earnings tomorrow before market open. Here’s what investors should know.
Via
StockStory
United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference
February 24, 2025
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025
February 19, 2025
From
United Therapeutics Corporation
Via
Business Wire
How Is The Market Feeling About United Therapeutics?
↗
November 26, 2024
Via
Benzinga
Earnings Outlook For United Therapeutics
↗
October 29, 2024
Via
Benzinga
Decoding 7 Analyst Evaluations For United Therapeutics
↗
October 21, 2024
Via
Benzinga
United Therapeutics (UTHR): Buy, Sell, or Hold Post Q3 Earnings?
February 14, 2025
United Therapeutics trades at $367.51 and has moved in lockstep with the market. Its shares have returned 13.5% over the last six months while the S&P 500 has gained 12.2%.
Via
StockStory
Topics
Stocks
United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
February 04, 2025
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial
February 03, 2025
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress
January 21, 2025
From
United Therapeutics Corporation
Via
Business Wire
The Analyst Landscape: 7 Takes On United Therapeutics
↗
October 21, 2024
Via
Benzinga
$100 Invested In United Therapeutics 5 Years Ago Would Be Worth This Much Today
↗
October 15, 2024
Via
Benzinga
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
↗
January 09, 2025
Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Government
United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces Successful World’s First UKidney Transplant
December 17, 2024
From
United Therapeutics Corporation
Via
Business Wire
Peering Into United Therapeutics's Recent Short Interest
↗
October 10, 2024
Via
Benzinga
United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
November 05, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
October 30, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
October 23, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024
October 23, 2024
From
United Therapeutics Corporation
Via
Business Wire
Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade
↗
October 15, 2024
Amphastar hit an all-time high in August 2023 and consolidated. It could be forming the right side of a cup base that started in January.
Via
Investor's Business Daily
Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits
↗
October 14, 2024
Alkermes develops treatments for neurodegenerative diseases (conditions that damage and destroy parts of the nervous system) and cancer.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
